Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hayal Ergin Toktaş"'
Autor:
Pınar Yalinay Dikmen, Betül Baykan, Derya Uludüz, Aynur Özge, Elif Ilgaz Aydınlar, Burcu Polat, Necdet Karlı, Nermin Tepe, Neşe Çelebisoy, Hayal Ergin Toktaş, Buket Niflioğlu, Rahşan Karacı, Füsun Mayda Domaç, Ezgi Uludüz, Tuba Erdogan Soyukibar, Nevra Öksüz, Mustafa Ertaş
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background The complexity of clinical practice extends far beyond the controlled settings of trials, and there is a need for real-world studies aimed at identifying which patients will respond to anti-CGRP monoclonal antibodies in different
Externí odkaz:
https://doaj.org/article/7aa45a0c64a442199df69a0c31c39789
Autor:
Esra Aydin Sunbul, Özgür Ulutaş, Hüseyin Güleç, Hayal Ergin Toktaş, Merve Karaca, Buğra Çetin
Publikováno v:
Sleep and Breathing. 24:1591-1598
Sleep disturbances such as nonrestorative sleep and nighttime awakenings play a crucial role in fibromyalgia (FMS). Pain and sleep disturbances show a bidirectional relationship which affect outcomes in FMS. This study aims to compare sleep structure
Autor:
Turgay Isbir, Seda Gulec Yilmaz, Hüseyin Güleç, Hayal Ergin Toktaş, Özgür Ulutaş, Buğra Çetin
PubMed ID: 29549784
We aimed to investigate the changes in the objective and subjective sleep variables during painful episodes of fibromyalgia and post-episode period, and to evaluate the impact of the sleep variables on the current clinical, p
We aimed to investigate the changes in the objective and subjective sleep variables during painful episodes of fibromyalgia and post-episode period, and to evaluate the impact of the sleep variables on the current clinical, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1690116fa4d4f76a7db7e02e99197a9e
https://hdl.handle.net/20.500.11831/3001
https://hdl.handle.net/20.500.11831/3001
Publikováno v:
Yeni Symposium. 53:57
Treatment resistance is an important issue in patients with depressive disorder and nearly a third of patients may not reach remission despite multiple drug trials. Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder in which daytime s